GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Techno Medica Co 6678.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

2,153

+1.22%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥11.24bn

FY2017FY2026

Net income

¥1.07bn

FY2017FY2026

Free cash flow

¥1.07bn

FY2017FY2026

Shareholders' equity

¥14.41bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥11.24bn¥9.91bn¥10.28bn¥9.37bn¥9.70bn¥9.04bn¥9.81bn¥9.33bn¥8.65bn¥8.46bn
Gross profit¥5.24bn¥4.88bn¥5.10bn¥4.59bn¥4.78bn¥4.42bn¥4.47bn¥4.34bn¥3.98bn¥4.11bn
Research and development—¥690.5m¥516.3m¥369.3m¥405.5m¥433.3m¥676.3m¥559.4m¥446.1m¥657.3m
Operating income¥1.67bn¥1.30bn¥1.84bn¥1.65bn¥1.86bn¥1.61bn¥1.26bn¥1.52bn¥1.66bn¥1.42bn
Net income¥1.07bn¥1.00bn¥1.35bn¥1.15bn¥1.28bn¥1.15bn¥1.00bn¥1.10bn¥1.31bn¥458.1m
Diluted earnings per share160.74144.79194.54145.71151.82135.62117.78129.49152.6553.16

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥17.97bn¥17.94bn¥17.43bn¥19.44bn¥18.51bn¥17.55bn¥16.57bn¥16.16bn¥15.49bn¥14.12bn
Cash and short-term investments¥8.98bn¥9.06bn¥8.59bn¥11.75bn¥11.52bn¥10.14bn¥9.76bn¥9.52bn¥9.33bn¥8.24bn
Total liabilities¥3.56bn¥3.55bn¥3.62bn¥3.06bn¥2.86bn¥2.59bn¥2.42bn¥2.41bn¥2.48bn¥1.95bn
Debt——¥319.3m¥98.8m¥114.5m¥134.3m¥147.8m¥129.6m−¥77.0m−¥46.1m
Shareholders' equity¥14.41bn¥14.39bn¥13.82bn¥16.39bn¥15.65bn¥14.96bn¥14.15bn¥13.74bn¥13.02bn¥12.17bn
Shares outstanding7m7m7m8m8m9m8m8m9m9m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥1.10bn¥977.5m¥1.14bn¥887.2m¥2.06bn¥825.4m¥1.27bn¥704.3m¥1.52bn¥695.5m
Capital spending−¥34.2m−¥24.9m−¥38.2m−¥138.7m−¥80.2m−¥33.9m−¥425.5m−¥73.1m−¥59.4m−¥35.9m
Free cash flow¥1.07bn¥952.7m¥1.10bn¥748.5m¥1.98bn¥791.5m¥843.8m¥631.2m¥1.46bn¥659.6m
Dividends paid−¥471.1m−¥470.2m−¥508.4m−¥505.1m−¥434.2m−¥415.3m−¥402.9m−¥385.8m−¥369.9m−¥370.1m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥2.20bn¥4.00bn¥3.13bn¥2.35bn¥1.76bn¥3.46bn¥2.33bn¥2.12bn
Gross profit¥1.05bn¥1.83bn¥1.46bn¥1.15bn¥811.8m¥1.68bn¥1.17bn¥1.07bn
Operating income¥236.7m¥838.8m¥563.0m¥269.4m−¥2.9m¥715.9m¥279.7m¥54.2m
Net income¥159.0m¥610.3m¥257.6m¥186.6m¥16.5m¥577.7m¥205.0m¥48.3m
Diluted earnings per share23.8691.5937.1326.902.3883.2729.586.97
Cash from operations———¥134.0m————
Capital spending———−¥22.0m————
Free cash flow———¥112.0m————
Total assets¥16.24bn¥17.97bn¥16.95bn¥16.56bn¥16.66bn¥17.94bn¥16.44bn¥16.49bn
Cash and short-term investments¥8.68bn¥8.98bn¥8.75bn¥8.81bn¥8.67bn¥9.06bn¥8.95bn¥9.53bn
Shareholders' equity¥13.71bn¥14.41bn¥14.47bn¥14.15bn¥13.93bn¥14.39bn¥13.81bn¥13.61bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.3%4.4%2.2%
Operating income0.4%0.7%0.2%
Net income-2.4%-1.5%-1.1%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin47.9%48.6%48.7%47.6%
Operating margin14.0%15.8%16.7%16.6%
Net margin9.8%11.2%11.8%11.5%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings13.415.59.415.211.412.113.416.113.736.9
Price to sales1.31.61.21.91.51.51.41.92.12.0

Dividends and splits

Per share, in the currency the company pays

Paid for 19 years. Last went ex-dividend on 30 Mar 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year136.0068.0060.0060.0051.0049.0047.0045.00
  • 300-for-1 split · 26 Sept 2013

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.